{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:33:56Z","timestamp":1772580836632,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,7,14]],"date-time":"2009-07-14T00:00:00Z","timestamp":1247529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/bf03345754","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T19:00:41Z","timestamp":1397156441000},"page":"832-836","source":"Crossref","is-referenced-by-count":19,"title":["High angiotensin II state without cardiac remodeling (Bartter\u2019s and Gitelman\u2019s syndromes): Are angiotensin II type 2 receptors involved?"],"prefix":"10.1007","volume":"32","author":[{"given":"L. A.","family":"Cal\u00f2","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Montisci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Scognamiglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Pagnin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Schiavo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mormino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Semplicini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Palatini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. C.","family":"Pessina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,14]]},"reference":[{"key":"BF03345754_CR1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990, 322: 1561\u20136.","journal-title":"N Engl J Med"},{"key":"BF03345754_CR2","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/01.hjh.0000165625.79933.9a","volume":"23","author":"P Gosse","year":"2005","unstructured":"Gosse P. Left ventricular hypertrophy as a predictor of cardiovascular risk. J Hypertens Suppl 2005, 23: S27\u201333.","journal-title":"J Hypertens Suppl"},{"key":"BF03345754_CR3","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","volume":"92","author":"PK Mehta","year":"2007","unstructured":"Mehta PK, Griendling KK. Angiotensin II Cell Signaling. Physiological and Pathological Effects in the Cardiovascular System. Am J Physiol Cell Physiol 2007, 92: C82\u201397.","journal-title":"Am J Physiol Cell Physiol"},{"key":"BF03345754_CR4","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/01.CIR.0000141573.44737.5A","volume":"110","author":"RB Devereux","year":"2004","unstructured":"Devereux RB, Dahl\u00f6f B, Gerdts E, et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol. The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial. Circulation 2004, 110: 1456\u201362.","journal-title":"Circulation"},{"key":"BF03345754_CR5","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.1996.03530430051039","volume":"275","author":"RE Schmieder","year":"1996","unstructured":"Schmieder RE, Martus P, and Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta analysis of randomized double-blind studies. JAMA 1996, 275: 1507\u201313.","journal-title":"JAMA"},{"key":"BF03345754_CR6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000076752","volume":"96","author":"M Naesens","year":"2004","unstructured":"Naesens M, Steels P, Verberckmoes R, Vanrenterghem Y, Kuypers D. Bartter\u2019s and Gitelman\u2019s syndromes: from gene to clinic. Nephron Physiol 2004, 96: 65\u201378.","journal-title":"Nephron Physiol"},{"key":"BF03345754_CR7","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.ki.5000253","volume":"69","author":"LA Cal\u00f2","year":"2006","unstructured":"Cal\u00f2 LA. Vascular tone control in humans: the utility of studies in Bartter\u2019s\/Gitelman\u2019s syndromes. Kidney Int 2006, 69: 963\u20136.","journal-title":"Kidney Int"},{"key":"BF03345754_CR8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/HJH.0b013e328010d4d2","volume":"25","author":"LA Cal\u00f2","year":"2007","unstructured":"Cal\u00f2 LA, Pessina AC. RhoA\/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans. J Hypertens 2007, 25: 259\u201364.","journal-title":"J Hypertens"},{"key":"BF03345754_CR9","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/ndt\/gfn118","volume":"23","author":"LA Cal\u00f2","year":"2008","unstructured":"Cal\u00f2 LA, Puato M, Schiavo S, et al. Absence of vascular remodeling in a high angiotensin II state (Bartter\u2019s and Gitelman\u2019s syndromes). Implications for angiotensin II signaling pathways. Nephrol Dial Transplant 2008, 23: 2804\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03345754_CR10","first-page":"1","volume":"11","author":"S O\u2019Regan","year":"1985","unstructured":"O\u2019Regan S, Heitz F, Davignon A. Echocardiography assessment of left ventricular function in patients with hypokalemia. Miner Electrolyte Metab 1985, 11: 1\u20134.","journal-title":"Miner Electrolyte Metab"},{"key":"BF03345754_CR11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000169085","volume":"17","author":"L Cal\u00f2","year":"1997","unstructured":"Cal\u00f2 L, Scognamiglio R, Nistri S, et al. Evidence of myocardial dysfunction in Bartter\u2019s syndrome. Am J Nephrol 1997, 17: 124\u20137.","journal-title":"Am J Nephrol"},{"key":"BF03345754_CR12","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/ndt\/gfh204","volume":"19","author":"PE Foglia","year":"2004","unstructured":"Foglia PE, Bettinelli A, Tosetto C, et al. Cardiac work up in primary renal hypokalaemia-hypomagnesaemia (Gitelman syndrome). Nephrol Dial Transplant 2004, 19: 1398\u2013402.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03345754_CR13","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1210\/jc.2004-0498","volume":"89","author":"LA Calo","year":"2004","unstructured":"Calo LA, Pagnin E, Davis PA, et al. Increased Expression of Regulator of G Protein Signaling-2 (RGS-2) in Bartter\u2019s\/Gitelman\u2019s Sydrome. A Role in the Control of Vascular Tone and Implication for Hypertension. J Clin Endocrinol Metab 2004, 89: 4153\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345754_CR14","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/HJH.0b013e3282f60d98","volume":"26","author":"LA Cal\u00f2","year":"2008","unstructured":"Cal\u00f2 LA, Pagnin E, Ceolotto G, et al. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter\u2019s\/Gitelman\u2019s syndromes. J Hypertens 2008, 26: 938\u201345.","journal-title":"J Hypertens"},{"key":"BF03345754_CR15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","volume":"2","author":"NB Schiller","year":"1989","unstructured":"Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989, 2: 358\u201367.","journal-title":"J Am Soc Echocardiogr"},{"key":"BF03345754_CR16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","volume":"57","author":"RB Devereux","year":"1986","unstructured":"Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57: 450\u20138.","journal-title":"Am J Cardiol"},{"key":"BF03345754_CR17","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1172\/JCI26384","volume":"115","author":"VJ Dzau","year":"2005","unstructured":"Dzau VJ and Lopez-Ilasaca M. Searching for transcriptional regulators of Ang II-induced vascular pathology. J Clin Invest 2005, 115: 2319\u201322.","journal-title":"J Clin Invest"},{"key":"BF03345754_CR18","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1172\/JCI24403","volume":"115","author":"Y Zhan","year":"2005","unstructured":"Zhan Y, Brown C, Maynard E, et al. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest 2005, 115: 2508\u201316.","journal-title":"J Clin Invest"},{"key":"BF03345754_CR19","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/ndt\/gfg204","volume":"18","author":"LA Cal\u00f2","year":"2003","unstructured":"Cal\u00f2 LA, Pagnin E, Davis PA, Sartori M, Semplicini A. Oxidative stress related factors in Bartter\u2019s and Gitelman\u2019s syndromes: relevance for Angiotensin II signalling. Nephrol Dial Transplant 2003, 18: 1518\u201325.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03345754_CR20","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1523-1755.2001.060003882.x","volume":"60","author":"L Cal\u00f2","year":"2001","unstructured":"Cal\u00f2 L, Ceolotto G, Milani M, et al. Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes. Kidney Int 2001, 60: 882\u20139.","journal-title":"Kidney Int"},{"key":"BF03345754_CR21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2002.00128.x","volume":"61","author":"L Calo","year":"2002","unstructured":"Calo L, Davis PA, Semplicini A. Reduced content of alpha subunit of Gq protein in monocytes of Bartter and Gitelman syndromes: Relationship with vascular hyporeactivity. Kidney Int 2002, 61: 353\u20134.","journal-title":"Kidney Int"},{"key":"BF03345754_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2006.11.007","volume":"7","author":"T Wieland","year":"2007","unstructured":"Wieland T, Lutz S, Chidiac P. Regulators of G protein signaling: a spotlight on emerging functions in the cardiovascular system. Curr Opin Pharmacol 2007, 7: 1\u20137.","journal-title":"Curr Opin Pharmacol"},{"key":"BF03345754_CR23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1172\/JCI200317836","volume":"111","author":"TH Le","year":"2003","unstructured":"Le TH, Coffman TM. RGS2. A \u201cturn-off\u201d in hypertension. J Clin Invest 2003, 111: 441\u20133.","journal-title":"J Clin Invest"},{"key":"BF03345754_CR24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/01.hjh.0000226202.80689.8f","volume":"24","author":"A Semplicini","year":"2006","unstructured":"Semplicini A, Lenzini L, Sartori M, et al. Reduced expression of regulator of G protein signaling-2 in hypertensive patients increases calcium mobilization and ERK1\/2 phosphorylation induced by angiotensin II. J Hypertens 2006, 24: 1115\u201324.","journal-title":"J Hypertens"},{"key":"BF03345754_CR25","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/00004872-200308000-00001","volume":"21","author":"M Volpe","year":"2003","unstructured":"Volpe M, Musumeci B, De Paolis P, Savoia C, Morganti A. Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular diseases? J Hypertens 2003, 21: 1429\u201343.","journal-title":"J Hypertens"},{"key":"BF03345754_CR26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.RES.87.9.753","volume":"87","author":"JL Hansen","year":"2000","unstructured":"Hansen JL, Servant G, Baranski TJ, Fujita T, Iiri T, Sheikh SP. Functional reconstitution of the angiotensin II type 2 receptor and Gi activation. Circ Res 2000, 87: 753\u20139.","journal-title":"Circ Res"},{"key":"BF03345754_CR27","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.HYP.0000228997.88162.a8","volume":"48","author":"PM Abadir","year":"2006","unstructured":"Abadir PM, Periasamy A, Carey RM, Siragy HM. Angiotensin II type 2 receptor bradykinin B2 receptor functional heterodimerization. Hypertension 2006, 48: 316\u201322.","journal-title":"Hypertension"},{"key":"BF03345754_CR28","first-page":"12","volume":"51","author":"L Calo","year":"1999","unstructured":"Calo L, Davis PA, Milani M, et al. Increased endothelial nitric oxide synthase mRNA level in Bartter\u2019s and Gitelman\u2019s syndrome. Relationship to vascular reactivity. Clin Nephrol 1999, 51: 12\u20137.","journal-title":"Clin Nephrol"},{"key":"BF03345754_CR29","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0272-6386(96)90514-4","volume":"27","author":"L Calo","year":"1996","unstructured":"Calo L, D\u2019Angelo A, Cantaro S, et al. Increased urinary NO2-\/NO3- and cyclic GMP levels in patients with Bartter\u2019s syndrome: relationship to vascular reactivity. Am J Kidney Dis 1996, 27: 874\u20139.","journal-title":"Am J Kidney Dis"},{"key":"BF03345754_CR30","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1097\/00004872-200410000-00019","volume":"22","author":"E Pagnin","year":"2004","unstructured":"Pagnin E, Davis PA, Sartori M, Semplicini A, Pessina AC, Calo LA. Rho kinase and PAI-1 in Bartter\u2019s\/Gitelman\u2019s syndromes: relationship to angiotensin II signaling. J Hypertens 2004, 22: 1963\u20139.","journal-title":"J Hypertens"},{"key":"BF03345754_CR31","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.amjhyper.2005.03.747","volume":"18","author":"E Pagnin","year":"2005","unstructured":"Pagnin E, Semplicini A, Sartori M, Pessina AC, Calo LA. Reduced mRNA and protein content of Rho guanine nucleotide exchange factor (RhoGEF) in Bartter\u2019s and Gitelman\u2019s syndromes. Relevance for the pathophysiology of hypertension. Am J Hypertens 2005, 18: 1200\u20135.","journal-title":"Am J Hypertens"},{"key":"BF03345754_CR32","doi-asserted-by":"crossref","unstructured":"Savoia C, Tabet F, Yao G, Schiffrin E, Touyz R. Negative regulation of Rho\/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats. J Hypertens 2005, 23: 1037\u201345.","DOI":"10.1097\/01.hjh.0000166845.49850.39"},{"key":"BF03345754_CR33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.HYP.0000050101.90932.14","volume":"41","author":"S Kurisu","year":"2003","unstructured":"Kurisu S, Ozono R, Oshima T, et al. Cardiac angiotensin II type 2 receptor activates the kinin\/NO system and inhibits fibrosis. Hypertension 2003, 41: 99\u2013107.","journal-title":"Hypertension"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345754.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03345754\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345754","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T11:47:32Z","timestamp":1565351252000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03345754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,14]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["BF03345754"],"URL":"https:\/\/doi.org\/10.1007\/bf03345754","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,14]]}}}